Last reviewed · How we verify

NCT06937645

the Effect of Hyaluronic Acid Intrauterine Wash on Endometrial Receptivity and Pregnancy Outcome

Recruiting now Phase 2 Last updated 22 April 2025
What this trial tests

Phase 2 trial testing Hyaluronic Acid (HA) in Infertile Patients in 120 participants. Currently enrolling.

Timeline
1 September 2023
Primary endpoint
1 May 2025
1 August 2025

Quick facts

Lead sponsorAl-Nahrain University
PhasePhase 2
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment120
Start date1 September 2023
Primary completion1 May 2025
Estimated completion1 August 2025
Sites1 location across Iraq

Drugs / interventions tested

Conditions studied

Sponsor

Al-Nahrain University

Who can join

Adults 18 to 40, female only, with Infertile Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hyaluronic acid intrauterine wash is done for infertile females undergoing intracytoplasmic sperm injection on the day of oocyte retrieval. endometrial receptivity parameters, including the subendometrial vasculature indices were measured before and after the intervention for purpose of studying the effect of hyaluronic acid on improvement of the endometrial receptivity and subsequently the pregnancy outcome

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Hyaluronic Acid (HA)

Trials testing the same drug.

Other Al-Nahrain University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06937645.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing